Disability evolution in multiple sclerosis: How to deal with missing transition times in the Markov model?

Neuroepidemiology

Volumn 28, Issue 1, 2007, Pages 56-64

  Petiot, V ^a   Quantin, C ^a   Le Teuff, G ^a   Chavance, M ^b   Binquet, C ^a   Abrahamowicz, M ^c,d   Moreau, T ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Markov model; Missing data; Multiple imputation; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHODOLOGY; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PROBABILITY; PROGNOSIS;

ADULT; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MARKOV CHAINS; MODELS, NEUROLOGICAL; MULTIPLE SCLEROSIS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33846864419     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098518     Document Type: Article

References (41)

1. Confavreux C, Aimard G, Devic M: Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
2. Kurtze JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;36:553-564.
3. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ: EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:671-676.
4. Confavreux C: Relapses, progression, inflammation and neurodegeneration in multiple sclerosis: a changing view. Adv Clin Neurosci Rehabil 2002;2:7-9.
5. Bjartmar C, Wujek TR, Trapp BD: Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurosci 2003;206:165-171.
6. Confavreux C, Vukusic S, Moreau T, Adeleine P: Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-1438.
7. Trojano M, Avolio C, Manzari C, Calo A, De Robertis F, Serio G, Livrea P: Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300-306.
8. Riise T, Gronning M, Fernandez O, Lauer K, Midgard R, Minderhoud JM, et al: Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand 1992;85:212-218.
9. Runmarker B, Andersen O: Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-134.
10. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC: The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
11. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al: The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
12. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
13. Phadke JG: Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990;113:1597-1628.
14. Phadke JG: Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry 1987;50:523-531.
15. Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL: Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness. J Chronic Dis 1977;30:819-830.
16. McAlpine D: The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 1961;84:186-203.
17. Cottrell DA, Kremenchutzky M, Rice GPA, Koopman WJ, Hader W, Baskerville A, et al: The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999;122:625-639.
18. Wolfson C, Confavreux C: A Markov model of the natural history of multiple sclerosis. Neuroepidemiology 1985;4:227-239.
19. Wolfson C, Confavreux C: Improvements to a simple Markov model of the natural history of multiple sclerosis. Neuroepidemiology 1987;6:101-115.
20. Confavreux C, Vukusic S, Adeleine P: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-778.
21. Alioum A, Commenges D: MKVPCI: a computer program for Markov models with piecewise constant transition intensities and covariates. Comput Methods Programs Biomed 2001;64:109-119.
22. Rubin DB: Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473-489.
23. Little RJA, Rubin DB: Statistical Analysis with Missing Data, ed 2. Hoboken, Wiley-Interscience, 2002.
24. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
25. McAlpine D: The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 1961;84:186-203.
26. Andersen PK: Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Stat Med 1988;7:661-670.
27. Kalbfeish JD, Lawless JF: The analysis of panel data under a Markov assumption. J Am Stat Assoc 1985;80:863-871.
28. Marshall G, Guo W, Jones RH: Markov: a computer program for multi-state Markov models with covariates. Comput Methods Programs Biomed 1995;47:147-156.
29. Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
30. Vercherin P, Gutknecht C, Guillemin F, Ecochard R, Mennen LI, Mercier M: Missing data mechanisms of the questionnaire SF-36's items in the SU.VI.MAX study. Rev Epidemiol Sante Publique 2003;51:513-525.
31. Rubin DB, Schenker N: Multiple imputation in health care databases: an overview and some applications. Stat Med 1991;10:585-598.
32. Allison P: Missing Data. Iowa City, Sage University Papers Series, 2001.
33. Levic ZM, Dujmovic I, Pekmezovic T, Jarebinski M, Marinkovic J, Stojsavljevic N, Drulovic J: Prognostic factors for survival in multiple sclerosis. Mult Scler 1999;5:171-178.
34. Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M: Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 2004;62:601-606.
35. Ghezzi A, Pozzilli C, Liguori M, Marrosu MG, Milani N, Milanese C, Simone I, Zaffaroni M: Prospective study of multiple sclerosis with early onset. Mult Scler 2002;8:115-118.
36. Eriksson M, Andersen O, Runmarker B: Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003;9:260-274.
37. Kantarci O, Siva A, Eraksoy M, Karabudak R, et al: Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 1998;51:765-772.
38. Riise T, Gronning M, Aarli JA, Nyland H, Larsen JP, Edland A: Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol 1988;41:1031-1036.
39. Runmarker B, Andersson C, Odén A, Andersen O: Prediction of outcome in multiple sclerosis based on multivariate models. J Neurol 1994;241:597-604.
40. Confavreux C, Vukusic S: Age at disability milestones in multiple sclerosis. Brain 2006;129:595-605.
41. Amato MP, Ponziani G, Bartolozzi ML, Siracusa G: A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J Neurol Sci 1999;168:96-106.